Janney Montgomery Scott LLC Cuts Stock Holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH)

Janney Montgomery Scott LLC reduced its position in VanEck Pharmaceutical ETF (NASDAQ:PPH) by 2.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,055 shares of the company’s stock after selling 133 shares during the period. Janney Montgomery Scott LLC’s holdings in VanEck Pharmaceutical ETF were worth $436,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently added to or reduced their stakes in the company. AAFMAA Wealth Management & Trust LLC raised its position in shares of VanEck Pharmaceutical ETF by 3.1% in the fourth quarter. AAFMAA Wealth Management & Trust LLC now owns 36,419 shares of the company’s stock worth $3,142,000 after acquiring an additional 1,100 shares during the period. Jane Street Group LLC grew its position in shares of VanEck Pharmaceutical ETF by 124.0% during the 3rd quarter. Jane Street Group LLC now owns 19,436 shares of the company’s stock valued at $1,847,000 after acquiring an additional 10,759 shares during the period. Stifel Financial Corp increased its stake in shares of VanEck Pharmaceutical ETF by 13.4% in the 3rd quarter. Stifel Financial Corp now owns 7,810 shares of the company’s stock valued at $742,000 after purchasing an additional 924 shares in the last quarter. Miller Investment Management LP raised its holdings in VanEck Pharmaceutical ETF by 13.4% in the 3rd quarter. Miller Investment Management LP now owns 207,535 shares of the company’s stock worth $19,722,000 after purchasing an additional 24,446 shares during the period. Finally, Beck Capital Management LLC boosted its position in VanEck Pharmaceutical ETF by 5.2% during the third quarter. Beck Capital Management LLC now owns 22,383 shares of the company’s stock worth $2,127,000 after purchasing an additional 1,109 shares in the last quarter.

VanEck Pharmaceutical ETF Price Performance

VanEck Pharmaceutical ETF stock opened at $89.40 on Monday. The stock has a market capitalization of $557.86 million, a PE ratio of 21.04 and a beta of 0.72. The business has a 50 day simple moving average of $87.76 and a 200-day simple moving average of $91.72. VanEck Pharmaceutical ETF has a 12 month low of $84.48 and a 12 month high of $99.51.

VanEck Pharmaceutical ETF Increases Dividend

The business also recently declared a dividend, which was paid on Monday, December 30th. Investors of record on Friday, December 27th were issued a $0.411 dividend. The ex-dividend date was Friday, December 27th. This is a positive change from VanEck Pharmaceutical ETF’s previous dividend of $0.36.

VanEck Pharmaceutical ETF Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.